Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (441-450 of 475) with videos related to

Pageof 48
Sort By:
Science Immunology|February 7, 2025
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myelomaRaphael Lutz, Alexandra M Poos, Llorenç Solé-Boldo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2022
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY ProjectMattia D'Agostino, David A Cairns, Juan José Lahuerta, et al.
Advances in Therapy|November 28, 2025
Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMentHermann Einsele, Philippe Moreau, Nizar Bahlis, et al.
The Lancet. Oncology|December 3, 2014
International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaS Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, et al.
Academic Radiology|July 10, 2025
Automated Detection of Focal Bone Marrow Lesions From MRI: A Multi-center Feasibility Study in Patients with Monoclonal Plasma Cell DisordersMarkus Wennmann, Jessica Kächele, Arvin von Salomon, et al.
International Journal of Cancer|July 29, 2014
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere lengthDaniele Campa, Alessandro Martino, Judit Varkonyi, et al.
The Lancet. Oncology|June 5, 2019
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disordersJens Hillengass, Saad Usmani, S Vincent Rajkumar, et al.
Nature Communications|January 11, 2022
Functional dissection of inherited non-coding variation influencing multiple myeloma riskRam Ajore, Abhishek Niroula, Maroulio Pertesi, et al.
The New England Journal of Medicine|December 9, 2024
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple MyelomaMeletios A Dimopoulos, Peter M Voorhees, Fredrik Schjesvold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2024
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 TrialElias K Mai, Uta Bertsch, Ema Pozek, et al.
Pageof 48

Showing results (441-450 of 475) with videos related to

Sort By:
Pageof 48
Science Immunology|February 7, 2025
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myelomaRaphael Lutz, Alexandra M Poos, Llorenç Solé-Boldo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2022
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY ProjectMattia D'Agostino, David A Cairns, Juan José Lahuerta, et al.
Advances in Therapy|November 28, 2025
Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMentHermann Einsele, Philippe Moreau, Nizar Bahlis, et al.
The Lancet. Oncology|December 3, 2014
International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaS Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, et al.
Academic Radiology|July 10, 2025
Automated Detection of Focal Bone Marrow Lesions From MRI: A Multi-center Feasibility Study in Patients with Monoclonal Plasma Cell DisordersMarkus Wennmann, Jessica Kächele, Arvin von Salomon, et al.
International Journal of Cancer|July 29, 2014
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere lengthDaniele Campa, Alessandro Martino, Judit Varkonyi, et al.
The Lancet. Oncology|June 5, 2019
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disordersJens Hillengass, Saad Usmani, S Vincent Rajkumar, et al.
Nature Communications|January 11, 2022
Functional dissection of inherited non-coding variation influencing multiple myeloma riskRam Ajore, Abhishek Niroula, Maroulio Pertesi, et al.
The New England Journal of Medicine|December 9, 2024
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple MyelomaMeletios A Dimopoulos, Peter M Voorhees, Fredrik Schjesvold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2024
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 TrialElias K Mai, Uta Bertsch, Ema Pozek, et al.
Pageof 48